GuillaumeMonnier

Collaborateur

Paris + 33.1.56.59.39.40

Contact

Partager

Guillaume Monnier conseille les émetteurs et les banques dans le cadre d'opérations de marchés tant en equity qu’en dette ainsi que dans le cadre d'opérations de public M&A. Il intervient notamment en qualité de conseil lors d’introductions en bourse, d’augmentations de capital/placements privés, de cessions de blocs, d’émissions d’obligations convertibles et/ou échangeables, d’émissions d'obligations sous programmes EMTN et d'émissions standalone et d'opérations de liability management. En outre, Guillaume Monnier conseille régulièrement des sociétés cotées en France sur leurs obligations d'information périodique et permanente.

Depuis son arrivée chez Jones Day en 2020, Guillaume Monnier est notamment intervenu aux côtés d’émetteurs et de syndicats bancaires dans le cadre d’opérations de marché réalisées par Alchimie, Forsee Power, Lhyfe, Spartoo et Waga Energy (introductions en bourse), Dee Tech (SPAC), Aelis Farma, Compagnie des Alpes, Carbios, EDAP TMS, Forsee Power, MedinCell, OSE Immunotherapeutics, Valneva et Waga Energy (augmentations de capital/placements privés), Bombarbier et SC de l’Ermitage Saint Joseph (cessions de blocs), Bigben Interactive et Voltalia (obligations échangeables/convertibles), EDF(liability management), Sanofi/Opella Healthcare (public M&A) et H2O Innovation (retrait de la cote).

Avant de rejoindre Jones Day, Guillaume Monnier a exercé dans un cabinet d’avocats international à Paris.

Expérience

  • Sanofi to separate its consumer healthcare business, OpellaJones Day is acting as securities law counsel to Sanofi in the separation of Opella, its consumer healthcare business, and the announced sale of a 50% controlling stake.
  • Valneva raises €61 million in accelerated bookbuilding offeringJones Day advised Valneva SE, a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs, in connection with its capital €61 million private placement through an accelerated bookbuilding process.
  • Waga Energy raises €52 million in accelerated bookbuilding offeringJones Day advised Waga Energy, an independent producer of renewable biomethane (RNG) from landfill gas with operations in Europe and North America, on its €52 million accelerated bookbuilding private placement.
  • H20 Innovation delists its shares on Euronext Growth in ParisJones Day acted as French counsel to H20 Innovation Inc., a Canadian company listed on the Toronto Stock Exchange and on the multilateral trading facility of Euronext Growth in Paris, in connection with the delisting of its shares trading on Euronext Growth in Paris.
  • Forsee Power completes €50 million capital increaseJones Day advised Forsee Power, a French company listed on the regulated market of Euronext Paris which specializes in the design, manufacture, and marketing of intelligent battery systems for the electromobility market, in its capital increase without shareholders’ preferential subscription rights but with priority subscription period for an amount of approximately €50 million.
  • EDAP completes follow-on public offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on public offering of 3,066,667 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • Voltalia issues additional green bondsJones Day advised Voltalia in its offering of additional green bonds convertible into new shares and/or exchangeable for existing shares (OCEANEs Vertes) due 2025 (the “New Bonds”) for a nominal amount of approximately €50 million (the “Offering”) fully fungible with the OCEANEs Vertes issued in January 2021 for a total nominal amount of approximately €200 million due on January 13, 2025, (the “Existing Bonds”).
  • Bank of America Europe acts as presenting bank of Volkswagen Group, Attestor Limited and Pon Holdings BV’s tender offer for and acquisition of Europcar MobilityJones Day advised Bank of America Europe acting as presenting bank in the €2.6 billion tender offer for and acquisition of Europcar Mobility Group launched by a consortium comprised of Volkswagen Group, Attestor Limited and Pon Holdings BV.
  • Bryan Garnier & Co Limited, Natixis, and Portzamparc complete up to €124 million IPO of Lhyfe on EuronextJones Day represented Bryan Garnier & Co Limited, Natixis, and Portzamparc (BNP Paribas Group), as joint lead managers and joint bookrunners, in connection with the up to €124 million initial public offering of Lhyfe on the regulated market of Euronext in Paris.
  • Forsee Power completes €115 million offering and IPO on regulated market of Euronext in ParisJones Day advised Forsee Power in connection with its initial public offering on the regulated market of Euronext in Paris and an offering of up to €115 million.
  • Waga Energy completes €110 million IPO on Euronext in Paris, with green shoe optionJones Day advised Waga Energy, a French company specialized in the recovery of landfill gas as biomethane, in connection with its €110 million initial public offering of Ordinary Shares on the regulated market of Euronext in Paris with an over-allotment option up to €123 million.
  • Natixis and TP ICAP Europe underwrite €31.4 million IPO of SpartooJones Day represented Natixis and TP ICAP Europe as joint global coordinators and joint bookrunners in connection with the €31.4 million initial public offering of Spartoo on Euronext Growth Paris.
  • Underwriters complete €231 million capital increase of Compagnie des AlpesJones Day represented a group of syndicate members in connection with the €231 million capital increase of Compagnie des Alpes, a leader in the leisure industry.
  • Deutsche Bank and Société Générale underwrite €165 million SPAC IPO by DEE TechJones Day represented Deutsche Bank, as sole global coordinator and joint bookrunner, and Société Générale, as joint bookrunner, in connection with the €165 million initial public offering by DEE Tech, the first ever French SPAC in the tech sector, which will be listed on the Professional Segment of the regulated market of Euronext Paris.
  • Underwriters complete €114 million capital increase of CarbiosJones Day represented the underwriters in connection with a capital increase of Carbios, a green chemistry company, of €114 million.
  • Bombardier sells entire stake in Alstom for €506 millionJones Day acted as French corporate and capital markets counsel to Bombardier Inc., a leading manufacturer of business jets, in the sale of its entire stake in Alstom S.A. for an amount of €506 million in an accelerated bookbuilt offering to qualified investors.
  • EDAP completes follow-on offering of American Depositary SharesJones Day represented EDAP TMS, a global leader in robotic energy-based therapies, in connection with its follow-on offering of 4,150,000 American Depositary Shares (ADSs) on the Nasdaq Global Market.
  • Berenberg, BNP Paribas, and TP ICAP Europe complete €87.3 million offering by Bigben Interactive of its inaugural senior conditionally secured bonds exchangeable into existing ordinary shares of NaconJones Day advised Berenberg, BNP Paribas, and TP ICAP Europe, as joint global coordinators and joint bookrunners, in connection with a €87.3 million offering by Bigben Interactive, a European player in video game development and publishing, in design and distribution of smartphone and gaming accessories as well as in audio products, of its inaugural senior conditionally secured bonds exchangeable into existing ordinary shares of Nacon due 2026.
  • SC de l’Ermitage Saint Joseph sells its interest in Pharmagest InteractiveJones Day represented SC de l’Ermitage Saint Joseph, a French société civile held by the founder and Chairman of the Board of Directors of Pharmagest, in the €73.6 million sale of all its shares in Pharmagest Interactive.
  • Bryan, Garnier & Co Limited and ODDO BHF SCA complete €29.8 million capital increase of MedinCell S.A.Jones Day represented Bryan, Garnier & Co Limited (acting via Bryan Garnier Securities SAS) and ODDO BHF SCA, as joint global coordinators and joint bookrunners, in connection with the €29.8 million capital increase of MedinCell S.A., a clinical stage pharmaceutical company.
    •

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.